[HTML][HTML] Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts
J Park, M Pabon, AMK Choi, II Siempos… - BMC pulmonary …, 2017 - Springer
Background Acute respiratory distress syndrome (ARDS) is potentially underrecognized by
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
[HTML][HTML] Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts
J Park, M Pabon, AMK Choi… - BMC …, 2017 - bmcpulmmed.biomedcentral.com
Acute respiratory distress syndrome (ARDS) is potentially underrecognized by clinicians.
Early recognition and subsequent optimal treatment of patients with ARDS may be facilitated …
Early recognition and subsequent optimal treatment of patients with ARDS may be facilitated …
Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: Validation in US and Korean cohorts
J Park, M Pabon, AMK Choi, II Siempos… - BMC Pulmonary …, 2017 - khu.elsevierpure.com
Background: Acute respiratory distress syndrome (ARDS) is potentially underrecognized by
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
[PDF][PDF] Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts
J Park, M Pabon, AMK Choi, II Siempos… - 2017 - academia.edu
Background: Acute respiratory distress syndrome (ARDS) is potentially underrecognized by
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts
J Park, M Pabon, AMK Choi, II Siempos… - BMC Pulmonary …, 2017 - dash.harvard.edu
Background: Acute respiratory distress syndrome (ARDS) is potentially underrecognized by
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
[HTML][HTML] Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts
J Park, M Pabon, AMK Choi, II Siempos… - BMC Pulmonary …, 2017 - ncbi.nlm.nih.gov
Background Acute respiratory distress syndrome (ARDS) is potentially underrecognized by
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts
J Park, M Pabon, AMK Choi, II Siempos… - BMC Pulmonary …, 2017 - go.gale.com
Background Acute respiratory distress syndrome (ARDS) is potentially underrecognized by
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts
J Park, M Pabon, AMK Choi… - BMC pulmonary …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Acute respiratory distress syndrome (ARDS) is potentially underrecognized by
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts
J Park, M Pabon, AMK Choi, II Siempos… - BMC PULMONARY …, 2017 - scholarworks.bwise.kr
Background: Acute respiratory distress syndrome (ARDS) is potentially underrecognized by
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
Plasma surfactant protein-D as a diagnostic biomarker for acute respiratory distress syndrome: validation in US and Korean cohorts.
J Park, M Pabon, AMK Choi, II Siempos… - BMC Pulmonary …, 2017 - europepmc.org
Background Acute respiratory distress syndrome (ARDS) is potentially underrecognized by
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …
clinicians. Early recognition and subsequent optimal treatment of patients with ARDS may …